Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Adjusted SG&A Expense $M by Year
Adjusted SG&A Expense $M ($M)
Thermo Fisher Scientific Adjusted SG&A Expense $M: $7,065M in FY2025, up 0.8% from a year earlier.
Latest, FY2025
7,065
Period ended Dec 31, 2025
Change on a year earlier
+0.8%
7,010 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Adjusted SG&A expense (non-GAAP measure) 6,510 15.2 % 7,010 16.3 % 7,065 15.9 %”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted SG&A Expense $M ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,065 | +0.8% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 7,010 | +7.7% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 6,510 | -8.2% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 7,090 | +5.9% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2021 | Dec 31, 2021 | 6,698 | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Adjusted SG&A Expense $M ($M), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/adj-sga-m
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.